Basics Harmony Biosciences Holdings, Inc. IPO Date: August 19, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.07B Activated in VL: True Average Daily Range Avg Daily Range: $0.79 | 2.12% Avg Daily Range (30 D): $0.54 | 1.49% Avg Daily Range (90 D): $0.52 | 1.49% Institutional Daily Volume Avg Daily Volume: .4M Avg Daily Volume (30 D): .45M Avg Daily Volume (90 D): .49M Trade Size Avg Trade Size (Sh.): 52 Avg Trade Size (Sh.) (30 D): 42 Avg Trade Size (Sh.) (90 D): 43 Institutional Trades Total Inst.Trades: 1,906 Avg Inst. Trade: $2.29M Avg Inst. Trade (30 D): $2.66M Avg Inst. Trade (90 D): $2.74M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.84M Avg Closing Trade (30 D): $3.25M Avg Closing Trade (90 D): $3.55M Avg Closing Volume: 77.75K     News Apr 8, 2025 @ 5:00 PM Developmental and Epileptic Encephalopathies Marke... Source: Delveinsight Jan 22, 2025 @ 6:00 PM 5-HT2 Agonist Clinical Trial Pipeline Appears Robu... Source: Delveinsight Dec 19, 2024 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight Oct 14, 2024 @ 2:46 PM Dravet Syndrome Drug Pipeline Research Report 2024... Source: Researchandmarkets.Com Aug 6, 2024 @ 12:45 PM Harmony Biosciences Holdings, Inc. (HRMY) Surpasse... Source: Zacks.Com Financials   TTM Q2 2025 Q1 2025 Basic EPS $3.16 $.69 $.79 Diluted EPS $3.1 $.68 $.78 Revenue $ 772.53M $ 200.49M $ 184.73M Gross Profit $ 605.19M $ 162.34M $ 152.74M Net Income / Loss $ 180.9M $ 39.78M $ 45.56M Operating Income / Loss $ 221.86M $ 48.18M $ 56.25M Cost of Revenue $ 167.33M $ 38.15M $ 31.99M Net Cash Flow $ 228.75M $ 57.05M $ 36M PE Ratio 11.66